HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy

As PI3K/Akt signaling is frequently deregulated in a wide variety of human tumors, PI3K inhibitors are an emerging class of drugs for cancer treatment. The monitoring of the drug behavior and distribution in the biological system can play an important role for targeted therapy and provide informatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ju-Hee, Jung, Kyung Hee, Lee, Hyunseung, Son, Mi Kwon, Yun, Sun-Mi, Ahn, Sung-Hoon, Lee, Kyeong-Ryoon, Lee, Soyoung, Kim, Donghee, Hong, Sungwoo, Hong, Soon-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259414/
https://www.ncbi.nlm.nih.gov/pubmed/25338206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259414/
https://www.ncbi.nlm.nih.gov/pubmed/25338206

Ejemplares similares